| Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells NR Mathew, F Baumgartner, L Braun, D O'Sullivan, S Thomas, ... Nature medicine 24 (3), 282-291, 2018 | 263 | 2018 |
| Cytokines in graft-versus-host disease AS Henden, GR Hill The Journal of Immunology 194 (10), 4604-4612, 2015 | 211 | 2015 |
| MHC class II antigen presentation by the intestinal epithelium initiates graft-versus-host disease and is influenced by the microbiota M Koyama, P Mukhopadhyay, IS Schuster, AS Henden, J Hülsdünker, ... Immunity 51 (5), 885-898. e7, 2019 | 189 | 2019 |
| Recipient mucosal-associated invariant T cells control GVHD within the colon A Varelias, MD Bunting, KL Ormerod, M Koyama, SD Olver, J Straube, ... The Journal of clinical investigation 128 (5), 1919-1936, 2018 | 92 | 2018 |
| Acute graft-versus-host disease is regulated by an IL-17–sensitive microbiome A Varelias, KL Ormerod, MD Bunting, M Koyama, KH Gartlan, RD Kuns, ... Blood, The Journal of the American Society of Hematology 129 (15), 2172-2185, 2017 | 73 | 2017 |
| Infectious complications of CAR T-cell therapy: a clinical update AG Stewart, AS Henden Therapeutic Advances in Infectious Disease 8, 20499361211036773, 2021 | 58 | 2021 |
| A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis GA Kennedy, SK Tey, L Buizen, A Varelias, KH Gartlan, C Curley, ... Blood, The Journal of the American Society of Hematology 137 (14), 1970-1979, 2021 | 38 | 2021 |
| IL-6 dysregulation originates in dendritic cells and mediates graft-versus-host disease via classical signaling AN Wilkinson, K Chang, RD Kuns, AS Henden, SA Minnie, KS Ensbey, ... Blood, The Journal of the American Society of Hematology 134 (23), 2092-2106, 2019 | 38 | 2019 |
| Incidence and outcomes of invasive fungal disease in adult patients with acute lymphoblastic leukemia treated with hyperfractionated cyclophosphamide, vincristine, doxorubicin … A Henden, K Morris, N Truloff, M Nakagaki, GA Kennedy Leukemia & lymphoma 54 (6), 1329-1331, 2013 | 28 | 2013 |
| Donor T-cell–derived GM-CSF drives alloantigen presentation by dendritic cells in the gastrointestinal tract KH Gartlan, M Koyama, KE Lineburg, K Chang, KS Ensbey, RD Kuns, ... Blood advances 3 (19), 2859-2865, 2019 | 25 | 2019 |
| Flt-3L Expansion of Recipient CD8α+ Dendritic Cells Deletes Alloreactive Donor T Cells and Represents an Alternative to Posttransplant Cyclophosphamide for the … KA Markey, RD Kuns, DJ Browne, KH Gartlan, RJ Robb, JP Martins, ... Clinical Cancer Research 24 (7), 1604-1616, 2018 | 25 | 2018 |
| IFN-λ therapy prevents severe gastrointestinal graft-versus-host disease AS Henden, M Koyama, RJ Robb, A Forero, RD Kuns, K Chang, ... Blood, The Journal of the American Society of Hematology 138 (8), 722-737, 2021 | 22 | 2021 |
| CMV exposure drives long-term CD57+ CD4 memory T-cell inflation following allogeneic stem cell transplant AC Yeh, A Varelias, A Reddy, SM Barone, SD Olver, K Chilson, ... Blood, The Journal of the American Society of Hematology 138 (26), 2874-2885, 2021 | 20 | 2021 |
| Pegylated interferon-2α invokes graft-versus-leukemia effects in patients relapsing after allogeneic stem cell transplantation AS Henden, A Varelias, J Leach, E Sturgeon, J Avery, J Kelly, S Olver, ... Blood advances 3 (20), 3013-3019, 2019 | 18 | 2019 |
| Catastrophic tumour lysis syndrome following single dose of imatinib C Keane, A Henden, R Bird European journal of haematology 82 (3), 244-245, 2009 | 13 | 2009 |
| Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells NR Mathew, F Baumgartner, L Braun, D O'Sullivan, S Thomas, ... Nature Medicine 24 (4), 526-526, 2018 | 8 | 2018 |
| Myeloid and lymphoid neoplasm with FGFR1 abnormality C Keane, A Henden, T Mills, P Wood British journal of haematology 145 (4), 440-440, 2009 | 5 | 2009 |
| Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over … AM Peri, F Edwards, A Henden, PNA Harris, MD Chatfield, DL Paterson, ... Clinical and Experimental Medicine 23 (8), 4563-4573, 2023 | 3 | 2023 |
| PET assessment of acute gastrointestinal graft versus host disease AP Scott, A Henden, GA Kennedy, SK Tey Bone Marrow Transplantation 58 (9), 973-979, 2023 | 1 | 2023 |
| High incidence of resistant breakthrough invasive fungal infections (IFD) in patients treated for acute gastrointestinal graft-versus-host disease (GI GVHD) following … Y Yuan, P Wong, JP Butler, A Henden, C Curley, S Durrant, H Mediwake, ... Bone Marrow Transplantation 57 (11), 1712-1715, 2022 | 1 | 2022 |
